- Johnson & Johnson (NYSE:JNJ) has begun clinical trial of a preventive Ebola vaccine regimen in Sierra Leone, which will combine two vaccine components from Crucell Holland and Janssen Pharmaceutical.
- Is the Ebola outbreak finally over? For the first time since the disease was reported in March 2014, the World Health Organization reported no new cases over the past week.
- According to the WHO, this is part of a trend: The number of cases in West African countries has remained below 10 per week over the past three months, but that doesn't mean the virus cannot surface again.
- A total of 11,297 are said to have died since the start of the epidemic.